國家衛生研究院 NHRI:Item 3990099045/11058
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912640      線上人數 : 1233
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11058


    題名: Metformin and helicobacter pylori infection in patients with type 2 diabetes
    作者: Tseng, CH
    貢獻者: National Institute of Environmental Health Sciences
    摘要: Patients with diabetes have an increased risk of gastric cancer (1,2), and metformin may protect against gastric cancer (3). This study investigated whether metformin might protect against Helicobacter pylori infection, an important risk factor of gastric cancer.The reimbursement database of Taiwan ’ s National Health Insurance was used. Disease diagnoses were based on the ICD-9-CM. Diabetes was coded 250. XX, and H. pylori infection was de fi ned by a diagnostic code of 041.86 plus receiving H. pylori eradication therapy (4). A propensity score (PS)-matched cohort (based on the Greedy 8 → 1 digit match algorithm) (3) comprised 16,060 metformin ever users and 16,060 metformin never users with new-onset diabetes, who were enrolled during 1999 – 2005 and followed up until the end of 2011. Patients with type 1 diabetes, cancer diagnoses, or H. pylori infections at entry or within 6 months of diabetes diagnosis, aged , 25 or . 75 years at entry, or with a follow-up duration , 6 months were not included. PS was derived from covariates including age, sex, occupation, living region, hypertension, dyslipidemia, obesity, nephropathy, eye disease, stroke, ischemic heart disease, peripheral arterial disease, chronic obstructive pulmonary disease, tobacco abuse, alcohol-related diagnoses, heart failure, gingival and periodontal diseases, pneumonia, osteoporosis, tuberculosis infection, disease of pancreas, diseases of esophagus, stomach, and duodenum, Epstein Barr virus infection, hepatitis B virus infection, hepatitis C virus infection, and use of insulin, sulfonylureas, meglitinides, acarbose, rosiglitazone, pioglitazone, ACE inhibitors/ angiotensin receptor blockers, calcium channel blockers, statins, fi brates, and aspirin. Hazard ratios (HRs) were estimated by Cox regression incorporated with the inverse probability of treatment weighting using PS (3). Standardized difference was calculated for each covariate, and a cutoff . 10% may indicate potential confounding (5).
    日期: 2018-02-01
    關聯: Diabetes Care. 2018 Apr;41(4):E42-E43.
    Link to: http://dx.doi.org/10.2337/dc17-2551
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0149-5992&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000428000000002
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85044511976
    顯示於類別:[其他] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB29437699.pdf523KbAdobe PDF190檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋